Achyranthes bidentatapolypeptide protects dopaminergic neurons from apoptosis in Parkinson's disease models both in vitro and in vivo
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background and Purpose: Parkinson's disease (PD) is a neurodegenerative disorder closely associated with dopaminergic neuron loss. It is well documented thatAchyranthes bidentatapolypeptides (ABPP) are potent neuroprotective agents in several kinds of neurons. Therefore, we proposed that ABPP might play a beneficial role against PD by protecting dopaminergic neurons from apoptosis. Experimental Approach: SH‐SY5Y cells and primary rat dopaminergic neurons were pretreated with ABPP fraction k (ABPPk), a purified fraction of ABPP, and then the cells were exposed to 1‐methyl‐4‐phenylpyridinium iodide (MPP+) to induce apoptosis. Cell viability, LDH activity, a Tunel assay and protein levels of Bcl‐2 and Bax were analysed. In an in vivo PD model induced by MPTP, ABPPk was intranasally delivered to mice. Behavioural tests, immunohistochemistry, immunostaining, Nissl staining, qRT‐PCR and Western blot were employed to evaluate the potential effects of ABPPk on PD in mice. Key Results: The application of ABPPk markedly enhanced the viability of SH‐SY5Y cells and primary dopaminergic neurons treated with neurotoxic agent MPP+. In an in vivo MPTP‐induced PD model, ABPPk significantly improved behavioural performances and prevented tyrosine hydroxylase loss in the substantia nigra pars compacta and striatum. Furthermore, we showed that MPTP‐induced astrocyte and microglia activation were largely attenuated by ABPPk, leading to low levels of neuroinflammation and a downregulation of the apoptotic signalling pathway. Conclusion and Implications: Taken together, our data show that ABPPk protects dopaminergic neurons from apoptosis, suggesting that ABPPk might be an effective intervention for treating the neuron loss associated with disorders such as PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00872.x · Cited by 3,625
Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.220 · Cited by 2,012
How neuroinflammation contributes to neurodegeneration
Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967 · cited 1×
“ABPPk attenuates microglia and astrocyte activation Chronic low-grade inflammation has been demonstrated as a principal causative factor for incidence of PD (Ransohoff, 2016).”
BackgroundMcGrath, J. C., & Lilley, E. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12955 · Cited by 1,321
Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J., Latchman, D. S., Tabrizi, S. J., Wood, N. W., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.013 · Cited by 682
Inflammation in Parkinson’s disease: role of glucocorticoids
Herrero, M.-T., Estrada, C., Maatouk, L., & Vyas, S. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00032 · Cited by 175 · cited 1×
“Increasing evidence shows that neuroinflammation plays a significant role in the pathogenesis of PD (Herrero et al., 2015).”
Background
Cited by
SIRT1 attenuates neuroinflammation by deacetylating HSPA4 in a mouse model of Parkinson's disease
Yang, Y., Zhang, S., Guan, J., Jiang, Y., Zhang, J., Luo, L., & Sun, C. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166365 · Cited by 41
Self-citationLin, L.-W., Tsai, F.-H., Lan, W.-C., Cheng, Y.-D., Lee, S.-C., & Wu, C.-R. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1436-7 · Cited by 31
He, X., Yang, S., Zhang, R., Hou, L., Xu, J., Hu, Y., Xu, R., Wang, H., & Zhang, Y. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00018 · Cited by 27
Metadata
- Authors
- Peng, S., Wang, C., Ma, J., Jiang, K., Jiang, Y., Gu, X., & Sun, C.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2018-01-06
- Volume
- 175
- Issue
- 4
- Pages
- 631-643
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2769144835
- Cited by
- 60
- References
- 6
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Achyranthes bidentatapolypeptide protects dopaminergic neurons from apoptosis in Parkinson's disease models both in vitro and in vivo. https://app.cochat.ai/papers/10.1111/bph.14110
- The paper
- Peng, S., Wang, C., Ma, J., Jiang, K., Jiang, Y., Gu, X., & Sun, C. (2018). Achyranthes bidentatapolypeptide protects dopaminergic neurons from apoptosis in Parkinson's disease models both in vitro and in vivo. British Journal of Pharmacology. https://doi.org/10.1111/bph.14110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.